Finance
The company plans to use the funds to focus on the oncology space.
Berlin-based digital health company plans to expand in the US market.
The deal is worth $250 million in cash and stock.
This additional funding brings the company's total Series B raise to $120 million.
The acquisition will cost $53.5 million in cash, plus an earnout consideration of up to $24 million and around $5 million in stock to employees joining Doximity.
Also: VisuWell scores $10 million for its telehealth tool, and Epicore Biosystems picks up $10 million for its hydration wearable.
The financing completes firm’s $60.1M Series B round.
Tryl is focused on curbing clinical trial dropout rates through personalized patient engagement.
Also: Koda Health scoops up $3.5 million, and Wavely Diagnostics raises $2 million.
The connected fitness company will also stop developing a manufacturing site and cut its warehousing and logistics operations.